ArticleOncotarget2018
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells.
Daniela Catanzaro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it